Costs of chronic obstructive pulmonary disease in Sweden

S. A. Jansson, A. Ericsson, E. Jönsson, S. Borg, E. Rönmark, F. Andersson, B. Lundbäck (Luleå, Umeå, Lund, Stockholm, Sweden)

Source: Annual Congress 2002 - Prevalence and costs of COPD
Session: Prevalence and costs of COPD
Session type: Thematic Poster Session
Number: 830
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. A. Jansson, A. Ericsson, E. Jönsson, S. Borg, E. Rönmark, F. Andersson, B. Lundbäck (Luleå, Umeå, Lund, Stockholm, Sweden). Costs of chronic obstructive pulmonary disease in Sweden. Eur Respir J 2002; 20: Suppl. 38, 830

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epidemiology and costs of chronic obstructive pulmonary disease - Supplementary material: Final Q and A Global Burden of COPD
Source: Eur Respir J 2006; 27: 188-207
Year: 2006

Epidemiology and costs of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 27: 188-207
Year: 2006


Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003; 21: 58-67
Year: 2003



The year in chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical Year in Review
Year: 2018


Telemedicine in chronic obstructive pulmonary disease
Source: Breathe 2016; 12: 350-356
Year: 2016



Awareness of chronic obstructive pulmonary disease (COPD) in Portugal
Source: Eur Respir J 2007; 30: Suppl. 51, 126s
Year: 2007

Prevalence of chronic obstructive pulmonary disease (COPD) in Greece
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002

Mortality in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001

Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002

Comorbidities in the course of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


The problems of chronic obstructive pulmonary disease in Kyrgyzstan
Source: Eur Respir J 2005; 26: Suppl. 49, 296s
Year: 2005

Costs and effectiveness of a disease management program for chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012


Economic burdens of patients with chronic obstructive pulmonary disease (COPD) in Japan
Source: Eur Respir J 2006; 28: Suppl. 50, 108s
Year: 2006

Etiologies of exacerbations of the chronic obstructive pulmonary disease in Tunisia
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013


Exacerbations in chronic obstructive pulmonary disease (COPD) in Ontario, Canada
Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2
Year: 2021



Socioeconomic burden of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=463
Year: 2006

Diabetes and chronic obstructive pulmonary disease
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019


Prevalence of chronic obstructive pulmonary disease (COPD) in primary care
Source: Annual Congress 2008 - Issues in the management of COPD in the community
Year: 2008


Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation
Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure
Year: 2003